FDA scolds drugmaker over promotion that touts ‘misleading’ comparison with generics The agency said a study did not support Edenbridge Pharmaceuticals’ claims

https://www.statnews.com/pharmalot/2025/03/04/fda-myeloma-promotion-misleading-edenbridge-dexcel/